These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 16752940)

  • 1. New strategies for antibacterial drug design: targeting non-multiplying latent bacteria.
    Coates AR; Hu Y
    Drugs R D; 2006; 7(3):133-51. PubMed ID: 16752940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting non-multiplying organisms as a way to develop novel antimicrobials.
    Coates AR; Hu Y
    Trends Pharmacol Sci; 2008 Mar; 29(3):143-50. PubMed ID: 18262665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for novel antibacterial agents based on the activities of compounds on metabolism of Escherichia coli: a microcalorimetric study.
    Kong W; Wang J; Xing X; Jin C; Xiao X; Zhao Y; Zhang P; Zang Q; Li Z
    J Hazard Mater; 2011 Jan; 185(1):346-52. PubMed ID: 20926184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel approaches to developing new antibiotics for bacterial infections.
    Coates AR; Hu Y
    Br J Pharmacol; 2007 Dec; 152(8):1147-54. PubMed ID: 17704820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When will the genomics investment pay off for antibacterial discovery?
    Mills SD
    Biochem Pharmacol; 2006 Mar; 71(7):1096-102. PubMed ID: 16387281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The millennium bugs--the need for and development of new antibacterials.
    Bax R; Mullan N; Verhoef J
    Int J Antimicrob Agents; 2000 Sep; 16(1):51-9. PubMed ID: 11185414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural products--the future scaffolds for novel antibiotics?
    Butler MS; Buss AD
    Biochem Pharmacol; 2006 Mar; 71(7):919-29. PubMed ID: 16289393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Narrow versus broad spectrum antibacterials: factors in the selection of pneumococcal resistance to beta-lactams.
    Carbon C; Isturiz R
    Drugs; 2002; 62(9):1289-94. PubMed ID: 12076179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of conventional and alternative strategies for developing new antibacterial agents.
    Oancea S
    Acta Chim Slov; 2010 Sep; 57(3):630-42. PubMed ID: 24061811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterials: are the new entries enough to deal with the emerging resistance problems?
    Barrett CT; Barrett JF
    Curr Opin Biotechnol; 2003 Dec; 14(6):621-6. PubMed ID: 14662392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of antibacterial activity and minimum inhibitory concentration of larval extract of fly via resazurin-based turbidometric assay.
    Teh CH; Nazni WA; Nurulhusna AH; Norazah A; Lee HL
    BMC Microbiol; 2017 Feb; 17(1):36. PubMed ID: 28209130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting virulence not viability in the search for future antibacterials.
    Heras B; Scanlon MJ; Martin JL
    Br J Clin Pharmacol; 2015 Feb; 79(2):208-15. PubMed ID: 24552512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Antibacterial Compounds and their Drug Targets - Successes and Challenges.
    Kaczor AA; Polski A; Sobótka-Polska K; Pachuta-Stec A; Makarska-Bialokoz M; Pitucha M
    Curr Med Chem; 2017; 24(18):1948-1982. PubMed ID: 27978802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future challenges facing the development of new antimicrobial drugs.
    Coates A; Hu Y; Bax R; Page C
    Nat Rev Drug Discov; 2002 Nov; 1(11):895-910. PubMed ID: 12415249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research and development of antibacterial agents.
    Chopra I
    Curr Opin Microbiol; 1998 Oct; 1(5):495-501. PubMed ID: 10066523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterials - mechanisms of action.
    Piddock LJ
    Curr Opin Microbiol; 1998 Oct; 1(5):502-8. PubMed ID: 10066530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between target-class and the physicochemical properties of antibacterial drugs.
    Mugumbate G; Overington JP
    Bioorg Med Chem; 2015 Aug; 23(16):5218-24. PubMed ID: 25975639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. XF drugs: A new family of antibacterials.
    Pereira Gonzales F; Maisch T
    Drug News Perspect; 2010 Apr; 23(3):167-74. PubMed ID: 20440418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.